Large tech companies and their customer-centric business models have led to gains in efficiency that have benefitted consumers and businesses worldwide. At the same time, the cross-sectoral nature of these companies exposes the world to new...

Environmental, social, and governance (ESG) issues have become increasingly important in recent years for investors, spurring companies to be more socially responsible and open about their ESG efforts. This trend is particularly true for...

The cost of capital to conduct medical R&D is high because investors must be compensated with significant returns to offset the risky and long drug-development process. This cost of capital could be reduced, and thus medical innovation...

With the global economy gaining momentum following its recovery since 2008, and the new U.S. leadership’s refocusing from financial stability efforts to developing blueprints for economic growth, parts of the post-crisis macroprudential...

In the aftermath of the 2007-2008 financial crisis, new legislation and regulations have pressured banks and insurance companies to reduce their size, leverage, and riskier lines of business in order to avoid another too-big-to-fail debacle...

In the aftermath of the 2007-2008 financial crisis, new legislation and regulations have pressured banks and insurance companies to reduce their size, leverage, and riskier lines of business in order to avoid another too-big-to-fail debacle...

Do stock markets act as a “spare tire” during banking crises by providing an alternative form of corporate financing when the banking system goes flat? In 1999, Alan Greenspan, then chairman of the Federal Reserve, argued that stock markets...

On March 4, 2015, the Milken Institute Center for Financial Markets hosted a day-long roundtable, Framing the Issues: De-Risking and Its Consequences for Global Commerce and the Financial System, with AML/CFT policymakers, regulators...